OLVIG
WST icon

Oliver Lagore Vanvalin Investment Group’s West Pharmaceutical WST Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5
Closed -$1.65K – 774
2024
Q2 		$1.65K Hold
5
– – ﹤0.01% 615
2024
Q1 		$1.98K Hold
5
– – ﹤0.01% 618
2023
Q4 		$1.76K Hold
5
– – ﹤0.01% 638
2023
Q3 		$1.88K Buy
+5
New +$1.93K ﹤0.01% 701

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's WST Position: Q3 2024 in Review

Oliver Lagore Vanvalin Investment Group sold out of West Pharmaceutical (WST) in Q3 2024, closing a stake of 5 shares — an estimated $1.65K sold.

Oliver Lagore Vanvalin Investment Group first reported a position in WST in Q3 2023 and held it in 4 quarters. The position peaked at $1.98K in Q1 2024. 729 funds tracked by Wall St. Rank hold WST as of Q3 2024.

  • Oliver Lagore Vanvalin Investment Group reported no remaining West Pharmaceutical position as of Q3 2024 after selling out during the quarter.
  • Oliver Lagore Vanvalin Investment Group sold 5 West Pharmaceutical shares in Q3 2024, an estimated $1.65K.
  • Oliver Lagore Vanvalin Investment Group first reported a position in West Pharmaceutical in Q3 2023 and held it in 4 quarters.
  • Oliver Lagore Vanvalin Investment Group's West Pharmaceutical position peaked at $1.98K in Q1 2024.
  • 729 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q3 2024, filed 4 Nov 2024.